Hydroxyurea ulcers of unusual location: a case report and review of literature

[1] Kennedy BJ, Yarbro JW: Metabolic and therapeutic effects of hydroxyurea in chronic myelogenous leukemia. Trans Assoc Am Phys 78:391–399, 1965. KennedyBJ YarbroJW Metabolic and therapeutic effects of hydroxyurea in chronic myelogenous leukemia Trans Assoc Am Phys 78 391 399 1965 Search in Google Scholar

[2] Kennedy BJ: Hydroxyurea therapy in chronic myelogenous leukemia. Cancer 29:1052–1056, 1972. KennedyBJ Hydroxyurea therapy in chronic myelogenous leukemia Cancer 29 1052 1056 1972 Search in Google Scholar

[3] Daoud MS, Gibson LE, Pittelkow MR. Hydroxyurea dermopathy: a unique lichenoid eruption complicating longterm therapy with hydroxyurea. J Am Acad Dermatol 1997;36:178–82. DaoudMS GibsonLE PittelkowMR Hydroxyurea dermopathy: a unique lichenoid eruption complicating longterm therapy with hydroxyurea J Am Acad Dermatol 1997 36 178 82 Search in Google Scholar

[4] Bulte CA, Hoegler KM, Kutlu Ö, et al. Hydroxyurea: a reaprraisal of its cutaneous side effects and their management. Int J Dermatol. 2021;60(7):810–817. BulteCA HoeglerKM KutluÖ Hydroxyurea: a reaprraisal of its cutaneous side effects and their management Int J Dermatol. 2021 60 7 810 817 Search in Google Scholar

[5] Latagliata R, Spadea A, Cedrone M, et al; Gruppo Laziale SMPC Ph1 neg. Symptomatic mucocutaneous toxicity of hydroxyurea in Philadelphia chromosome-negative myeloproliferative neoplasms: the Mister Hyde face of a safe drug. Cancer. 2012 15;118(2):404–9. LatagliataR SpadeaA CedroneM Gruppo Laziale SMPC Ph1 neg Symptomatic mucocutaneous toxicity of hydroxyurea in Philadelphia chromosome-negative myeloproliferative neoplasms: the Mister Hyde face of a safe drug Cancer. 2012 15 118 2 404 9 Search in Google Scholar

[6] Stahl RL, Silber R. Vasculitic leg ulcers in chronic myelogenous leukemia. Am J Med 1985;78:869–72. StahlRL SilberR Vasculitic leg ulcers in chronic myelogenous leukemia Am J Med 1985 78 869 72 Search in Google Scholar

[7] Harrison CN, Campbell PJ, Buck G, et al. United Kingdom Medical Research Council Primary Thrombocythemia 1 Sutdy. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. N Engl J Med 2005;353:33–45. HarrisonCN CampbellPJ BuckG United Kingdom Medical Research Council Primary Thrombocythemia 1 Sutdy. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia N Engl J Med 2005 353 33 45 Search in Google Scholar

[8] Antonioli E, Guglielmelli P, Pieri L, et al., AGIMM investigators. Hydroxyurea-related toxicity in 3,411 patients with Ph’-negative MPN. Am J Hematol 2012;87:552–4. AntonioliE GuglielmelliP PieriL AGIMM investigators Hydroxyurea-related toxicity in 3,411 patients with Ph’-negative MPN Am J Hematol 2012 87 552 4 Search in Google Scholar

[9] Quattrone F, Dini V, Barbanera S, et al. Cutaneous ulcers associated with hydroxyurea therapy. Journal of Tissue Viability. 2013;22(4):112–121. QuattroneF DiniV BarbaneraS Cutaneous ulcers associated with hydroxyurea therapy Journal of Tissue Viability. 2013 22 4 112 121 Search in Google Scholar

[10] Hwang S-W, Hong S-K, Kim S-H, et al. A hydroxyurea-induced leg ulcer. Ann Dermatol 2009;21:39–41. HwangS-W HongS-K KimS-H A hydroxyurea-induced leg ulcer Ann Dermatol 2009 21 39 41 Search in Google Scholar

[11] Simeonovski V, Breshkovska H, Duma S, et al. Hydroxyurea Associated Cutaneous Lesions: A Case Report. Open Access Maced J Med Sci. 2018 19;6(8):1458–1461. SimeonovskiV BreshkovskaH DumaS Hydroxyurea Associated Cutaneous Lesions: A Case Report Open Access Maced J Med Sci. 2018 19 6 8 1458 1461 Search in Google Scholar

[12] Hartmann K, Nagel S, Erichesen T, et al. Cutaneous ulcers following hydroxyurea therapy. Phlebologie 2004;33:202–5. HartmannK NagelS ErichesenT Cutaneous ulcers following hydroxyurea therapy Phlebologie 2004 33 202 5 Search in Google Scholar

[13] Dissemond J, Hoeft D, Knab J, et al. Leg ulcer in a patient associated with hydroyurea therapy. Int J Dermatol 2006;45:158–60. DissemondJ HoeftD KnabJ Leg ulcer in a patient associated with hydroyurea therapy Int J Dermatol 2006 45 158 60 Search in Google Scholar

[14] Kikuchi K, Arita K, Tateishi Y, et al. Recurrence of hydroxyurea-induced leg ulcer after discontinuation of treatment. Acta Derm Venereol 2011;91:373–4. KikuchiK AritaK TateishiY Recurrence of hydroxyurea-induced leg ulcer after discontinuation of treatment Acta Derm Venereol 2011 91 373 4 Search in Google Scholar

[15] Natarajan S, Williamson D, Grey J, et al. Healing of an MRSA-colonized, hydroxyurea-induced leg ulcer with honey. J Dermatolog Treat 2001; 12:33–6. NatarajanS WilliamsonD GreyJ Healing of an MRSA-colonized, hydroxyurea-induced leg ulcer with honey J Dermatolog Treat 2001 12 33 6 Search in Google Scholar

[16] Fioramonti P, Fino P, Parisi P, et al. A case of hydroxyurea-induced leg ulcer after definitive treatment suspension in a patient affected by thrombocythemia: effectiveness of a new collagenase. In Vivo 2012;26:1053–6. FioramontiP FinoP ParisiP A case of hydroxyurea-induced leg ulcer after definitive treatment suspension in a patient affected by thrombocythemia: effectiveness of a new collagenase In Vivo 2012 26 1053 6 Search in Google Scholar